Cover Image
Market Research Report

Global Vitiligo Therapeutics Market 2018-2022

Published by TechNavio (Infiniti Research Ltd.) Product code 688087
Published Content info 107 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Vitiligo Therapeutics Market 2018-2022
Published: August 28, 2018 Content info: 107 Pages
Description

About Vitiligo Therapeutics

Vitiligo is the depigmentation of the skin cause by the death or malfunctioning of the melanocytes, which are responsible for the color of the skin. It occurs as patches on the skin and could also affect the hair and the inside of the mouth.

Technavio's analysts forecast the Global Vitiligo Therapeutics Market to grow at a CAGR of 4.41% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the vitiligo therapeutics market. To calculate the market size, the report considers the revenue generated from the retail sales of all approved medicines, generic medicines, and off-label drugs used in the treatment of vitiligo across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Vitiligo Therapeutics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Astellas Pharma
  • Bausch Health
  • Baxter
  • Mallinckrodt
  • Puneet Laboratories

Market driver

  • Rising importance of aesthetic appeal
  • For a full, detailed list, view our report

Market challenge

  • Poor patient adherence
  • For a full, detailed list, view our report

Market trend

  • Growing disposable income in emerging countries
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents
Product Code: IRTNTR23654

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: DISEASE OVERVIEW

PART 05: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 06: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 07: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 08: PIPELINE

PART 09: MARKET SEGMENTATION BY ROA

  • Segmentation by RoA
  • Comparison by RoA
  • Topical - Market size and forecast 2017-2022
  • Oral - Market size and forecast 2017-2022
  • Others - Market size and forecast 2017-2022
  • Market opportunity by RoA

PART 10: CUSTOMER LANDSCAPE

PART 11: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Americas - Market size and forecast 2017-2022
  • Key leading countries
  • Market opportunity

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 14: MARKET TRENDS

PART 15: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 16: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Astellas Pharma
  • Bausch Health
  • Baxter
  • Mallinckrodt
  • Puneet Laboratories

PART 17: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Parent market
  • Exhibit 02: Global vitiligo therapeutics market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global vitiligo therapeutics market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global vitiligo therapeutics market - Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Pipeline landscape by development phase
  • Exhibit 19: Key clinical trials
  • Exhibit 20: Global vitiligo therapeutics market segmentation by RoA
  • Exhibit 21: Global vitiligo therapeutics market segmentation by RoA - Market share 2017-2022 (%)
  • Exhibit 22: Comparison by RoA
  • Exhibit 23: Global vitiligo topical therapeutics market - Size and forecast 2017-2022 ($ mn)
  • Exhibit 24: Global vitiligo topical therapeutics market - Year-over-year growth 2018-2022 (%)
  • Exhibit 25: Global vitiligo oral therapeutics market - Size and forecast 2017-2022 ($ mn)
  • Exhibit 26: Global vitiligo oral therapeutics market - Year-over-year growth 2018-2022 (%)
  • Exhibit 27: Global vitiligo others therapeutics market - Size and forecast 2017-2022 ($ mn)
  • Exhibit 28: Global vitiligo others therapeutics market - Year-over-year growth 2018-2022 (%)
  • Exhibit 29: Market opportunity by RoA
  • Exhibit 30: Customer landscape
  • Exhibit 31: Global vitiligo therapeutics market - Market share by geography 2017-2022 (%)
  • Exhibit 32: Regional comparison
  • Exhibit 33: Global vitiligo therapeutics market in EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 34: Global vitiligo therapeutics market in EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 35: Global vitiligo therapeutics market in APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 36: Global vitiligo therapeutics market in APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 37: Global vitiligo therapeutics market in Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 38: Global vitiligo therapeutics market in Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 39: Key leading countries
  • Exhibit 40: Market opportunity
  • Exhibit 41: Economic snapshot of India and China
  • Exhibit 42: Vendor landscape
  • Exhibit 43: Landscape disruption
  • Exhibit 44: Vendors covered
  • Exhibit 45: Vendor classification
  • Exhibit 46: Market positioning of vendors
  • Exhibit 47: Astellas Pharma - Overview
  • Exhibit 48: Astellas Pharma - Business segments
  • Exhibit 49: Astellas Pharma - Organizational developments
  • Exhibit 50: Astellas Pharma - Geographic focus
  • Exhibit 51: Astellas Pharma - Segment focus
  • Exhibit 52: Astellas Pharma - Key offerings
  • Exhibit 53: Astellas Pharma - Key customers
  • Exhibit 54: Bausch Health - Overview
  • Exhibit 55: Bausch Health - Business segments
  • Exhibit 56: Bausch Health - Organizational developments
  • Exhibit 57: Bausch Health - Geographic focus
  • Exhibit 58: Bausch Health - Segment focus
  • Exhibit 59: Bausch Health - Key offerings
  • Exhibit 60: Bausch Health - Key customers
  • Exhibit 61: Baxter - Overview
  • Exhibit 62: Baxter - Business segments
  • Exhibit 63: Baxter - Organizational developments
  • Exhibit 64: Baxter - Geographic focus
  • Exhibit 65: Baxter - Segment focus
  • Exhibit 66: Baxter - Key offerings
  • Exhibit 67: Baxter - Key customers
  • Exhibit 68: Mallinckrodt - Overview
  • Exhibit 69: Mallinckrodt - Business segments
  • Exhibit 70: Mallinckrodt - Organizational developments
  • Exhibit 71: Mallinckrodt - Geographic focus
  • Exhibit 72: Mallinckrodt - Segment focus
  • Exhibit 73: Mallinckrodt - Key offerings
  • Exhibit 74: Mallinckrodt - Key customers
  • Exhibit 75: Puneet Laboratories - Overview
  • Exhibit 76: Puneet Laboratories - Business segments
  • Exhibit 77: Puneet Laboratories - Organizational developments
  • Exhibit 78: Puneet Laboratories - Geographic focus
  • Exhibit 79: Puneet Laboratories - Segment focus
  • Exhibit 80: Puneet Laboratories - Key offerings
  • Exhibit 81: Puneet Laboratories - Key customers
Back to Top